NYSE:ZTS

Zoetis (ZTS) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Zoetis shares closed at $125.49 after the early Dec. 24 session, near the lower half of their 52-week range. The company completed a $2.0 billion convertible notes offering, with $1.54 billion set for share repurchases through Q1 2026 and $248 million already used to buy back 2.1 million shares. Markets reopened Dec. 26 after the Christmas break.

26 December 2025

NYSE:ZTS·Stock Market

Zoetis Stock (ZTS) After Hours on Dec. 24, 2025: Price Action, Today’s Headlines, Analyst Forecasts, and What to Watch Before the Next Market Open

Zoetis shares closed up 1.6% at $125.50 in a shortened Christmas Eve session, then held steady in thin after-hours trading. About 2.36 million shares changed hands, with the day’s range between $123.06 and $125.68. The stock remains down roughly 24% over the past year. No major company news was released Dec. 24.

25 December 2025

NYSE:ZTS·Stock Market

Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis priced $1.75 billion in 0.25% convertible senior notes due 2029, with proceeds earmarked for share buybacks under its $6 billion repurchase program. Morgan Stanley cut its price target to $160 from $175, citing growth and competition concerns. Zoetis shares closed up 1.9% on Dec. 16 but remain far below early 2025 highs. The notes deal is set to close Dec. 18.

17 December 2025

Dividends·NYSE:ZTS·Share Buybacks

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis reported 2024 revenue of $9.3 billion, up 9% from 2023, with gross margins near 72% and net profit margin around 29%. Shares traded at $130–$135 in November 2025, down from a 52-week high of $180. The company raised its dividend by 15% to $2.00 per share. Analysts’ average 12-month target is $188, though some issued downgrades in late 2025 amid slowing growth.

4 November 2025

Biotechnology·NYSE:ZTS·Pharmaceutical Industry

Bajaj Broking Recommends Belrise Industries and Jayaswal Neco Industries for March 20, 2026
March 19, 2026, 10:39 PM EDT. Bajaj Broking Research has recommended Belrise Industries and Jayaswal Neco Industries as top stock picks for March 20, 2026. Indian markets showed high volatility amid global geopolitical tensions and hawkish U.S. Federal Reserve policies. The Nifty 50 index reached 23,862 but lost momentum, maintaining a bearish trend with support near 23,000-22,950. Resistance stays at 23,862 and 24,300. The Bank Nifty continued its decline, risking drops toward 52,500 and 51,800, key Fibonacci retracement levels. Elevated oil prices above $115 per barrel, driven by Middle East conflicts, add inflationary pressure and dampen market sentiment. Investors remain cautious, watching central bank moves and crude oil developments closely.